NCT Number: NCT00274664
Patching for Lazy Eye: Trial to Evaluate Daily Patching Amounts
Amblyopia ('lazy eye') is the commonest visual disorder of childhood and is caused by an interruption to visual development. Occlusion of the better eye by patching is the mainstay of treatment, so forcing use, of the affected eye. We have little understanding of how much treatment is required for improvement, so occlusion may continue for many months. This is both demanding for the child and family as a whole. Treatment outcome is frequently unsatisfactory. Compliance is often poor, thus we do not know precisely how much treatment the child actually receives or how much is required.
To overcome this, we have designed an instrument that permits us to measure occlusion: an occlusion dose monitor (ODM) which provides an objective record of how much occlusion a child actually receives. Recently we have observed that 75% of improvement induced by occlusion occurs in the first four weeks of treatment. In this study we explore the possibility that by intensive treatment the period of amblyopia therapy can be shortened - i.e. treatment will be more efficient, more effective, and more 'family-friendly'. The study hypothesis is that 12 hours/day of patching is more effective than 6 hours/day.
Looking for future studies?
Notify MeKey information
Conditions
Age range
3 year–8 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
Primary location
St Marys Hospitals, London, Greater London, United Kingdom
About this study
The identification and subsequent management of amblyopia are major consumers of health service resource, and within the hospital sector account for around 80-90% of visits to the children's eye service. Occlusion of the better eye is the mainstay of treatment and because we have little understanding of the dose-response relationship this may continue for many months and sometimes for many hundreds of hours. This is demanding for the child and family as a whole and yet the outcome is frequently unsatisfactory. Currently, there is no reliable data on the kinetics of visual improvement, so occlusion tends to be prescribed on an ad hoc basis. Recent pilot research has shown that 75% of the treatment-generated improvement occurs within the first 4 weeks when 6 hours/day occlusion is prescribed.
In this study we explore the possibility that by intensive treatment the period of amblyopia therapy can be shortened - i.e. made both more efficient and hopefully more effective. The purpose of the present study, the Randomized Occlusion Treatment of Amblyopia Study (ROTAS), is to compare two frequently employed patching regimens: 'substantial' (6 hrs/day) against 'maximal' (12 hrs/day) patching. Our experimental design incorporates objective occlusion monitoring and is able to discriminate the beneficial effect of refractive correction from that of occlusion. The study comprises three phases: 'baseline', 'refractive adaptation' and 'occlusion.' Our aim is to provide guidelines for patient management based, for the first time, on experimentally determined and statistically verifiable relationships between treatment and outcome.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 3 to 8 years of age;
- Presence of anisometropia and/or strabismus;
- inter-ocular acuity difference of at least 0.1 logMAR
- parental consent
Exclusion criteria
- history of previous occlusion therapy
- ocular pathology
- learning difficulties
Treatment and study plan
12 hours occlusion by patching
DevicePrimary outcomes
-
The primary outcome measure was logMAR visual acuity, measured 6-weekly for 18 weeks in refractive adaptation phase. In occlusion phase measured 2-weekly until no further gains
Sponsors and collaborators
Lead sponsor
City, University of London
Other
Collaborators
- Imperial College London
Registry information
Official study title
Randomised Occlusion Treatment of Amblyopia Study (ROTAS): Trial of Maximal Vs Substantial Doses of Occlusion to Evaluate Visual Outcome for Children With Amblyopia
Important dates
- Study start
- 2002
- Study completion
- 2005
- First posted
- Jan 11, 2006
- Registry last updated
- Jan 11, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Binocular Dig Rush Game Treatment for Amblyopia
NCT02983552
Amblyopia, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsEffectiveness of Virtual Reality Training in Amblyopia
NCT05732467
Amblyopia, Brain Diseases
Hangzhou, Zhejiang, China
View Trial DetailsRehabilitation Training Games for Children With Amblyopia
NCT06372548
Adherence, Treatment, Amblyopia
Shanghai, Shanghai Municipality, China
View Trial DetailsVision Therapy Outcomes in Amblyopia: Linking Brain Plasticity With Visual Perceptual Skills
NCT07437807
Amblyopia, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial Details